Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
100.00%
Operating Margin
43.94%
Net Margin
16.95%
Efficiency Metrics
Revenue per Expense Ratio
1.78
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
43.94%
Income Tax Rate
21.87%
EPS
5.2400000000
Balance Sheet Analysis
Current Ratio
89,232,000,000.0
Cash Ratio
89,232,000,000.0
Working Capital
$89.23B
Debt to Equity
2.79
Debt to Assets
23.15%
Equity Ratio
8.30%
Cash Flow Analysis
Operating Cash Flow Ratio
-62.55%
Free Cash Flow Ratio
-68.92%
CapEx to Revenue
6.36%
Dividends Paid
$5.76B
Stock Buybacks
$6.18B
Total Shareholder Returns
$11.94B
Cash Position Change
-30.36%
Key Takeaways (2023 FY)
Increased dividend payments by 10.83%
Detailed Growth Metrics
Core Performance
Revenue
0.42%
Net Income
-17.61%
EPS
-15.89%
Operating Income
-4.37%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
4.52%
Operating Cash Flow
-424.25%
Free Cash Flow
-289.95%
Balance Sheet Health
Assets
1.14%
Debt
12.25%
Book Value per Share
2.59%
Inventory
100.00%
Shareholder Returns
Dividends per Share
10.83%
Shares Outstanding
-3.73%
Long Term Trends
3Y Revenue/Share
9.98%
5Y Revenue/Share
40.24%
3Y Dividend/Share
107.17%
5Y Dividend/Share
154.58%